Corvus Pharmaceuticals Inc (CRVS)
Healthcare
Biotechnology
13.40 $
+0.8%
vs. previous close
Closing price · As of: 3. Aug 2026
Corvus Pharmaceuticals Inc (CRVS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -10 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -5.2 | -5.4 | -5.2 | -5.2 | -5.5 | -6.3 | -8.5 | -8.3 | -5.8 | -9.6 | -9.2 | -10 | -35 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | |
| 0.5 | 0.5 | 0.6 | 0.7 | 0.8 | 0.7 | 0.8 | 1.3 | 1.3 | 1.2 | 1.6 | 2.7 | 6.7 | |
| 0.5 | – | – | – | – | – | – | – | – | – | – | – | – | |
| -0.3 | -0.6 | -0.4 | 0.2 | -0.5 | 0.3 | -1.5 | 0.2 | 2.9 | -0.6 | 1.1 | 0.1 | 3.5 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.1 | 0.2 | |
| -4.3 | 18 | -2.3 | 0.0 | -18 | -3.9 | -6.1 | 4.2 | -20 | -2.6 | 11 | -145 | -157 | |
| 7.5 | 0.3 | 0.0 | 0.0 | 30 | 0.1 | 19 | 0.3 | 36 | 0.4 | 0.0 | 191 | 227 | |
| -2.0 | 12 | -7.5 | -5.2 | 7.4 | -10 | 4.1 | -3.7 | 9.7 | -12 | 1.7 | 36 | 35 | |
| -5.2 | -5.4 | -5.2 | -5.2 | -5.5 | -6.3 | -8.5 | -8.3 | -5.9 | -9.6 | -9.2 | -10 | -35 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.